English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Positive airway pressure (PAP) is the first line therapy for adult obstructive sleep apnea (OSA). However, the effectiveness of PAP is limited by treatment adherence (1). Several recent emerging therapies for OSA were presented during the Sleep and Respiratory Neurobiology sessions at the 2016 ATS meeting in San Francisco. Of particular focus was the need for appropriate patient selection and individualized therapy.

Non positive airway pressure therapies for sleep disordered breathing from the ATS 2016